Literature DB >> 15758610

Genetic screening and diagnosis.

Tze Kin Lau1, Tse Ngong Leung.   

Abstract

PURPOSE OF REVIEW: To review the latest developments in screening and diagnosis of non-chromosomal genetic diseases. RECENT
FINDINGS: Major recent advances include the completion of the Human Genome Project, the use of microarray and related technologies for mass screening and diagnosis of thousands of genetic abnormalities, and non-invasive prenatal diagnosis using fetal DNA in maternal plasma.
SUMMARY: The rapid development in molecular biological technologies makes it possible to screen and to diagnosis thousands of genetic conditions, mutations and also predispositions to chronic diseases or traits, either prenatally or after birth. Clinical application of non-invasive prenatal diagnosis using fetal DNA in maternal plasma has become a reality. The arrival of the molecular genetic era also leads to many new ethical, social and medico-legal problems and dilemmas that obstetricians will have to face in the near future. There is an urgent need for the development of a new model for provision of genetic screening and diagnosis.

Entities:  

Mesh:

Year:  2005        PMID: 15758610     DOI: 10.1097/01.gco.0000162187.99219.e0

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  3 in total

1.  Microarray comparative genomic hybridization (CGH)-based prenatal diagnosis for chromosome abnormalities using cell-free fetal DNA in amniotic fluid.

Authors:  Shoko Miura; Kiyonori Miura; Hideaki Masuzaki; Noriko Miyake; Koh-Ichiro Yoshiura; Nadiya Sosonkina; Naoki Harada; Osamu Shimokawa; Daisuke Nakayama; Shuichiro Yoshimura; Naomichi Matsumoto; Norio Niikawa; Tadayuki Ishimaru
Journal:  J Hum Genet       Date:  2006-04-19       Impact factor: 3.172

2.  SPPS resins impact the PNA-syntheses' improvement.

Authors:  Rüdiger Pipkorn; Stephan Rawer; Manfred Wiessler; Waldemar Waldeck; Mario Koch; Hans Hermann Schrenk; Klaus Braun
Journal:  Int J Med Sci       Date:  2013-02-13       Impact factor: 3.738

3.  Comparison of different strategies in prenatal screening for Down's syndrome: cost effectiveness analysis of computer simulation.

Authors:  Jean Gekas; Geneviève Gagné; Emmanuel Bujold; Daniel Douillard; Jean-Claude Forest; Daniel Reinharz; François Rousseau
Journal:  BMJ       Date:  2009-02-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.